MarginsXMarginsX
Home › Markets › Health Care › PARK

Park Dental Partners Inc. (PARK)

PARK trades on Nasdaq in Health Care, Misc Health and Biotechnology Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$19.72
-8.24% on the day
Market cap
$109.2M
Micro cap
Revenue
New registrant: no annual report filed under this company yet
Net income
New registrant: no annual report filed under this company yet

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerPARK on Nasdaq
SectorHealth Care
IndustryMisc Health and Biotechnology Services
CountryUnited States
IPO year2025
SEC CIK0002069604
SEC industry codeServices-Misc Health & Allied Services, NEC
Incorporated inMN

Financials

New registrant: no annual report filed under this company yet.

Warning signs

Cash runway
Cash-flow positive
$23.2M cash at September 30, 2026
Share count, 1 year
No year-earlier count
Going-concern doubt
No
10-Q filed November 12, 2026
Insider net buying, 12 months
$226K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-12
Cash and burn$23.2M cash; operating cash flow $4.9M a quarter.Report 2026-09-30
Shares outstanding5,535,029 (2026-11-12).Cover page 2026-11-12
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, Minneapolis, Minnesota, United StatesPCAOB Form AP 2026-04-01
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $226K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$64.9M$1.7M$2.3M$23.2M$10.6MNeeds four quarters10-Q 2026-11-12
Q2 2026
2026-06-30
$66.2M$1.3M$4.7M$24.4M$11.0MNeeds four quarters10-Q 2026-08-13
Q1 2026
2026-03-31
$62.7M-$390K$5.0M$24.4M$11.5MNeeds four quarters10-Q 2026-05-14
Q3 2026
2025-09-30
$61.3M$1.3M$7.6M$8.4MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q2 2026
2025-06-30
$63.0M$2.6M$3.4M$2.9MNo debt tagsNeeds four quarters10-Q 2026-08-13
Q1 2026
2025-03-31
$59.0M$1.6M$5.9M$3.5MNo debt tagsNeeds four quarters10-Q 2026-05-14

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42025-12-03
Latest annual report10-K2026-03-25
Latest quarterly / interim10-Q2026-11-12
Latest current report8-K/A2026-11-13
Latest proxyDEFA14A2026-04-10

Source: SEC EDGAR submissions feed, 73 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+8.0%
1 month+9.7%
3 months-6.8%
Year to date+45.6%
1 yearNot enough price history
From 52-week high-6.8%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Misc Health and Biotechnology Services

TickerCompanyPriceDayMarket cap
CCELCryo-Cell International Inc.$4.55-6.19%$36.7M
VMDViemed Healthcare Inc. Common Shares$9.15-0.22%$346.7M
AGLagilon health inc.$116.75+0.94%$2.0B
PGNYProgyny Inc.$37.15+2.68%$2.7B
MGRXMangoceuticals Inc.$0.1603+3.42%$3.6M
SHCSotera Health Company$16.25-2.17%$4.6B
NIVFNewGenIvf Group Limited$0.2050-11.33%$2.0M
DVADaVita Inc.$174.22-0.19%$11.0B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier